Login

Switch On Your HIV Smarts.

Ending hepatitis C means including people who inject drugs

Ending hepatitis C means including people who inject drugs

, by Emily Land

Innovative HCV cure initiatives in San Francisco prioritize high-needs people who may still be actively injecting drugs. Read More

CROI 2018: A roundup of the most exciting PrEP news & research

CROI 2018: A roundup of the most exciting PrEP news & research

, by Liz Highleyman

Liz Highleyman summarizes the PrEP and HIV prevention research presented recently at the domestic HIV conference, CROI, including a new possible PrEP drug, real world PrEP effectiveness, and more. Read More

Status check: PrEP uptake & delivery

Status check: PrEP uptake & delivery

, by Emily Land

Dr. Kenneth Mayer discusses the state of PrEP uptake and delivery in the U.S., with an eye toward reducing barriers for people who may benefit from this method of HIV prevention. Read More

Biktarvy, a new HIV combo pill recently approved by the FDA

Biktarvy, a new HIV combo pill recently approved by the FDA

, by Jennifer Cocohoba, PharmD, AAHIVE

This week, the FDA granted approval of Gilead Science’s single-table combo pill of bictegravir, emtricitabine, and tenofovir alafenamide named Biktarvy. Read More

15% of people living with HIV in U.S. don’t know their status, new study estimates

15% of people living with HIV in U.S. don’t know their status, new study estimates

, by Emily Land

The percentage of people living with HIV in the U.S. who are undiagnosed is going down—although disparities by state and region of the country remain. Read More